Nostopharma
Nostopharma is on a mission to revolutionize orthopedic surgery with reduced complication rates for trauma victims.
Nostopharma is on a mission to revolutionize orthopedic surgery with reduced complication rates for trauma victims.
Nostopharma is a 2016-founded Health Care startup with headquarters in the United States. The company's ambition to revolutionize orthopedic surgery by reducing complication rates for trauma patients, athletes, and chronic inflammation victims is reflected in its slogan. In 21 June 2023, the company secured a noteworthy $250.00K Debt Financing investment. Although no specific investors are mentioned, this investment indicates that Nostopharma is attracting attention and support for its innovative approach to addressing the challenges within orthopedic surgery.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $250.00K | - | 21 Jun 2023 | |
| Grant | $256.00K | 1 |
|
18 Feb 2022 |
No recent news or press coverage available for Nostopharma.
We care about your data, and we'd love to use cookies make your experience better.
